Trials / Recruiting
RecruitingNCT02296307
DOvEE - Diagnosing Ovarian & Endometrial Cancer Early
Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 13,600 (estimated)
- Sponsor
- McGill University · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood test: CA-125 biomarker | * CA-125 biomarker blood test at visit 1, day 1. * CA-125 biomarker blood test at visit 2, week 6. |
| OTHER | Second Test: Transvaginal Ultrasound | -Transvaginal Ultrasound at visit 1, day 1. |
| OTHER | Follow-up phone call | Phone call 6 months after last visit to verify continued health. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2025-01-01
- Completion
- 2026-01-01
- First posted
- 2014-11-20
- Last updated
- 2024-05-02
Locations
8 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02296307. Inclusion in this directory is not an endorsement.